These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study. Wong TY; Shankar A; Klein R; Bray MS; Couper DJ; Klein BE; Sharrett AR; Folsom AR Ophthalmology; 2006 Feb; 113(2):255-9. PubMed ID: 16406547 [TBL] [Abstract][Full Text] [Related]
7. Reduced functional brain activity response in cognitively intact apolipoprotein E epsilon4 carriers. Lind J; Persson J; Ingvar M; Larsson A; Cruts M; Van Broeckhoven C; Adolfsson R; Bäckman L; Nilsson LG; Petersson KM; Nyberg L Brain; 2006 May; 129(Pt 5):1240-8. PubMed ID: 16537568 [TBL] [Abstract][Full Text] [Related]
8. Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischaemia. Horsburgh K; McCulloch J; Nilsen M; Roses AD; Nicoll JA Eur J Neurosci; 2000 Dec; 12(12):4309-17. PubMed ID: 11122341 [TBL] [Abstract][Full Text] [Related]
9. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos. Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760 [TBL] [Abstract][Full Text] [Related]
11. Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Persson J; Lind J; Larsson A; Ingvar M; Cruts M; Van Broeckhoven C; Adolfsson R; Nilsson LG; Nyberg L Neurology; 2006 Apr; 66(7):1029-33. PubMed ID: 16606914 [TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy. van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693 [TBL] [Abstract][Full Text] [Related]
13. The association between delirium and the apolipoprotein E epsilon4 allele in the elderly. van Munster BC; Korevaar JC; de Rooij SE; Levi M; Zwinderman AH Psychiatr Genet; 2007 Oct; 17(5):261-6. PubMed ID: 17728664 [TBL] [Abstract][Full Text] [Related]
14. APOE and modulation of Alzheimer's and frontotemporal dementia. Boccardi M; Sabattoli F; Testa C; Beltramello A; Soininen H; Frisoni GB Neurosci Lett; 2004 Feb; 356(3):167-70. PubMed ID: 15036621 [TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E genotype and mortality: findings from the Cache County Study. Hayden KM; Zandi PP; Lyketsos CG; Tschanz JT; Norton MC; Khachaturian AS; Pieper CF; Welsh-Bohmer KA; Breitner JC; J Am Geriatr Soc; 2005 Jun; 53(6):935-42. PubMed ID: 15935014 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease. Feldman B; Chapman J; Korczyn AD Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893 [TBL] [Abstract][Full Text] [Related]
17. The APOE polymorphism and 1-year outcome in ischemic stroke: genotype-gender interaction. Gromadzka G; Baranska-Gieruszczak M; Sarzynska-Dlugosz I; Ciesielska A; Czlonkowska A Acta Neurol Scand; 2007 Dec; 116(6):392-8. PubMed ID: 17986098 [TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease. Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913 [TBL] [Abstract][Full Text] [Related]
19. Impact of APOE status on cognitive maintenance in healthy elderly persons. Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849 [TBL] [Abstract][Full Text] [Related]
20. The effect of apolipoprotein polymorphism on brain in mild cognitive impairment: a voxel-based morphometric study. Pennanen C; Testa C; Boccardi M; Laakso MP; Hallikainen M; Helkala EL; Hänninen T; Kivipelto M; Könönen M; Nissinen A; Tervo S; Vanhanen M; Vanninen R; Frisoni GB; Soininen H Dement Geriatr Cogn Disord; 2006; 22(1):60-6. PubMed ID: 16682795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]